[Combined chemotherapy with asaline and cyclophosphane under experimental and clinical conditions].
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004407:Dysgerminoma / Q000188:drug therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D051379:Mice; D009101:Multiple Myeloma / Q000188:drug therapy; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D012510:Sarcoma 180 / Q000188:drug therapy; D012512:Sarcoma, Ewing / Q000188:drug therapy
D009588:Nitrogen Mustard Compounds; D003520:Cyclophosphamide
O sochetannoĭ khimioterapii asalinom i tsiklofosfanom v éksperimente i klinike.